Helper-Polymer Based Five-Element Nanoparticles (FNPs) for Lung-Specific mRNA Delivery with Long-Term Stability after Lyophilization

被引:40
作者
Cao, Yan [1 ]
He, Zongxing [1 ]
Chen, Qimingxing [1 ]
He, Xiaoyan [1 ]
Su, Lili [1 ]
Yu, Wenxia [1 ]
Zhang, Mingming [2 ]
Yang, Huiying [3 ]
Huang, Xingxu [1 ]
Li, Jianfeng [1 ]
机构
[1] ShanghaiTech Univ, Gene Editing Ctr, Sch Life Sci & Technol, Shanghai 201210, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Organ Chem, Interdisciplinary Res Ctr Biol & Chem, Shanghai 201210, Peoples R China
[3] Fudan Univ, Huashan Hosp, Dept Pharm, Shanghai 200040, Peoples R China
关键词
stability; lung-specific; five-element nanoparticles; poly(beta-amino esters); lyophilization; LIPID NANOPARTICLES; TREHALOSE; EFFICACY;
D O I
10.1021/acs.nanolett.2c01784
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Lipid nanoparticles (LNPs) carrying therapeutic mRNAs hold great promise in treating lung-associated diseases like viral infections, tumors, and genetic disorders. However, because of their thermodynamically unstable nature, traditional LNPs carrying mRNAs need to be stored at low temperatures, which hinders their prevalence. Herein, an efficient lung-specific mRNA delivery platform named five-element nanoparticles (FNPs) is developed in which helper-polymer poly(beta-amino esters) (PBAEs) and DOTAP are used in combination. The new strategy endows FNPs with high stability by increasing the charge repulsion between nanoparticles and the binding force of the aliphatic chains within the nanoparticles. The structure-activity relationship (SAR) shows that PBAEs with E1 end-caps, higher degrees of polymerization, and longer alkyl side chains exhibit higher hit rates. Lyophilized FNP formulations can be stably stored at 4 degrees C for at least 6 months. Overall, a novel delivery platform with high efficiency, specificity, and stability was developed for advancing mRNA-based therapies for lung-associated diseases.
引用
收藏
页码:6580 / 6589
页数:10
相关论文
共 50 条
  • [31] Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes
    Pardi, Norbert
    Tuyishime, Steven
    Muramatsu, Hiromi
    Kariko, Katalin
    Mui, Barbara L.
    Tam, Ying K.
    Madden, Thomas D.
    Hope, Michael J.
    Weissman, Drew
    [J]. JOURNAL OF CONTROLLED RELEASE, 2015, 217 : 345 - 351
  • [32] Pogocki D, 2000, J PHARM SCI-US, V89, P443, DOI 10.1002/(SICI)1520-6017(200004)89:4<443::AID-JPS2>3.0.CO
  • [33] 2-W
  • [34] Critical aspects of packaging, storage, preparation, and administration of mRNA and adenovirus-vectored COVID-19 vaccines for optimal efficacy
    Poland, Gregory A.
    [J]. VACCINE, 2021, 39 (03) : 457 - 459
  • [35] Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis
    Qiu, Min
    Tang, Yan
    Chen, Jinjin
    Muriph, Rachel
    Ye, Zhongfeng
    Huang, Changfeng
    Evans, Jason
    Henske, Elizabeth P.
    Xu, Qiaobing
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (08)
  • [36] Efficiency of Cytosolic Delivery with Poly(β-amino ester) Nanoparticles is Dependent on the Effective pKa of the Polymer
    Routkevitch, Denis
    Sudhakar, Deepti
    Conge, Marranne
    Varanasi, Mahita
    Tzeng, Stephany Y.
    Wilson, David R.
    Green, Jordan J.
    [J]. ACS BIOMATERIALS SCIENCE & ENGINEERING, 2020, 6 (06) : 3411 - 3421
  • [37] High-throughput and high-content bioassay enables tuning of polyester nanoparticles for cellular uptake, endosomal escape, and systemic in vivo delivery of mRNA
    Rui, Yuan
    Wilson, David R.
    Tzeng, Stephany Y.
    Yamagata, Hannah M.
    Sudhakar, Deepti
    Conge, Marranne
    Berlinicke, Cynthia A.
    Zack, Donald J.
    Tuesca, Anthony
    Green, Jordan J.
    [J]. SCIENCE ADVANCES, 2022, 8 (01)
  • [38] mRNA-based therapeutics - developing a new class of drugs
    Sahin, Ugur
    Kariko, Katalin
    Tuereci, Oezlem
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2014, 13 (10) : 759 - 780
  • [39] Lipid nanoparticles for nucleic acid delivery: Current perspectives
    Samaridou, Eleni
    Heyes, James
    Lutwyche, Peter
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2020, 154 : 37 - 63
  • [40] mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability
    Schoenmaker, Linde
    Witzigmann, Dominik
    Kulkarni, Jayesh A.
    Verbeke, Rein
    Kersten, Gideon
    Jiskoot, Wim
    Crommelin, Daan J. A.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 601